Treating H. pylori shorter than one week - A real future perspective?

Zeitschrift fur Gastroenterologie

Volumn 38, Issue 9, 2000, Pages 807-812

  Treiber, G ^a  

^a UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

Author keywords

Eradication therapy; Helicobacter pylori; Review; Short term

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; BISMUTH; CLARITHROMYCIN; IMIDAZOLE DERIVATIVE; LANSOPRAZOLE; MACROLIDE; METRONIDAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE; RANITIDINE BISMUTH CITRATE; TETRACYCLINE; TINIDAZOLE;

ANTIBIOTIC THERAPY; CLINICAL TRIAL; DRUG EFFICACY; ERADICATION THERAPY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; REVIEW; TREATMENT OUTCOME;

ANTIBIOTICS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMAN; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 0033791359     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-7530     Document Type: Review

References (55)

1. The impact of Helicobacter pylori eradication on peptic ulcer healing
2. Clinical aspects of helicobacter pylori eradication therapy in peptic ulcer disease
3. Meta-analysis of the relationship between helicobacter pylori seropositivity and gastric cancer
4. Helicobacter pylori infection induces gastric cancer in mongolian gerbils
5. Eradication on Helicobacter pylori: An objective assessment of current therapies
6. Treatment of helicobacter pylori infection: A review of the world literature
7. The influence of drug dosage on Helicobacter pylori eradication. A cost-effectiveness analysis
8. Current European concepts in the management of Helicobacter pylori infection - The Maastricht Consensus report
9. Review article: One-week clarithromycin triple therapy regimens for eradication of Helicobacter pylori
10. The European meeting on helicobacter pylori: Therapeutic news from Lisbon
11. Epidemiology and mechanism of antibiotic resistance in Helicobacter pylori
12. One-day intensified lansoprazole-quadruple therapy for cure of helicobacter pylori infection
13. Two-day weekend lasoprazole-quadruple therapy for helicobacter pylori infection
14. Anti-helicobacter pylori treatment in bleeding ulcers: Randomized controlled trial comparing 2-day vs. 7-day bismuth quadruple therapy
15. Only four days of quadruple therapy can effectively cure Helicobacter pylori infection
16. 4-Day lansoprazole quadruple therapy: A highly effective cure for Helicobacter pylori infection
17. Amoxicillin/ Metronidazole/ Omeprazole/ Clarithromycin: A new, short quadruple therapy for helicobacter pylori eradication
18. Azithromycin and increasing doses of omeprazole for the eradication of helicobacter pylori
19. Triple therapy for helicobacter pylori eradication in patients with chronic gastritis. Twelve days better than six
20. Efficacy of a 'one-day-triple-therapy' with potentialisation of omeprazole for eradication of helicobacter pylori
21. 6-Day eradication treatment of helicobacter pylori infection in a non-hospital practice
22. Efficacy of six days triple therapy with pantoprazole plus clarithromycin and amoxicillin versus omeprazole plus clarithromycin and amoxicillin for helicobacter pylori eradication
23. Only once a day for six days: Compliance effective triple-therapy against helicobacter pylori disease
24. Three-days and seven-days triple therapy with clarithromycin or azithromycin for cure of helicobacter pylori infection
25. Comparison of 2 three-day helicobacter pylori eradication regimens with a standard one week regimen
26. Ultra short-term triple therapy with azithromycin, tinidazole and pantoprazole appears highly effective for helicobacter pylori eradication
27. New short-term quadruple therapies for eradication of helicobacter pylori (H. pylori): MACLOR study
28. Weekend therapy for the treatment of Helicobacter pylori infection
29. Anti-Helicobacter pylori treatment in bleeding ulcers: Randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy
30. A four-day low dose triple therapy regimen for the treatment of Helicobacter pylori infection
31. Four-day lansoprazole-quadruple therapy in the routine treatment of Helicobacter pylori infection
32. One-day therapy for treatment of Helicobacter pylori infection
33. Lansoprazole triple therapy for helicobacter pylori - Is 5 days enough?
34. The optimal antibiotic combination in a 5-day Helicobacter pylori eradication regimen
35. Four-day quadruple therapy as a routine treatment for helicobacter pylori infection
36. A new dual and triple therapies in eradicating helicobacter pylori in peptic ulcer patients
37. Twice a day, four-day, quadruple therapy for treatment of helicobacter pylori infection: A pilot study
38. 3-Day antibiotic therapy with azithromycin and tinidazole plus lansoprazole or pantoprazole to cure helicobacter pylori infection
39. Short-term low-dose triple therapy with azithromycin, metronidazole and lansoprazole appears highly effective for the eradication of helicobacter pylori
40. Omeprazole and azithromycin with and without metronidazole in the eradication of Helicobacter pylori in duodenal ulcer disease
41. Cure of Helicobacter pylori infection in the elderly: Effects of eradication on gastritis and serological markers
42. Omeprazole plus 2 antibiotics for the eradication of H. pylori, are 5 days of treatment sufficient?
43. Optimal duration of therapy combining ranitidine bismuth citrate with clarithromycin and metronidazole in the eradication of Helicobacter pylori infection
44. Failure of a 1-day high-dose quadruple therapy for cure of Helicobacter pylori infection
45. Choosing the best anti-Helicobacter pylori therapy: Effect of antimicrobial resistance
46. Randomised study on the impact of resistance on second-line treatment after failed metronidazole-clarithromycin containing triple therapy
47. Impact of treatment duration and metronidazole resistance on H. pylori cure with omeprazole, metronidazole, and clarithromycin
48. Low rate of emergence of clarithromycin-resistant Helicobacter pylori with amoxycillin co-therapy
49. Do combinations with nitroimidazoles or amoxicillin prevent development of clarithromycin resistance in helicobacter pylori?
50. A new quadruple therapy for Helicobacter pylori: Influence of resistant strains on treatment outcome
51. Antibiotic resistance in Helicobacter pylori: Implications for therapy
52. Importance of Helicobacter pylori cag A and vac A status for the efficacy of antibiotic treatment
53. Cag negative status of Helicobactor pylori is a risk factor for failure of PPJ based triple therapies in non-ulcer dyspepsia